By NewsDesk  @bactiman63 Researchers this week published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored...

NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely...

By NewsDesk  @bactiman63 United BioPharma announced this week that Shanghai Public Health Clinical Centre and Cheng Kung University’s Department of Microbiology and Immunology have joined United...

By NewsDesk  @bactiman63 Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved a new low-dose tablet dosage form of Biktarvy® (bictegravir 30 mg/emtricitabine 120...

Merck and Ridgeback Biotherapeutics announced recently that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization or death at...

By NewsDesk  @infectiousdiseasenews From a press release from Juntendo University in Bunkyo City, Tokyo (computer translated): Malaria is transmitted from person to person through mosquitoes and causes...

By NewsDesk  @infectiousdiseasenews Recently, the Utah Department of Health became aware of a patient who ingested large doses of ivermectin in an attempt to treat symptoms of COVID-19. The patient suffered...

NewsDesk  @infectiousdiseasenews As the threat of resistance to current malaria treatment grows, Novartis and MMV have reported positive results of a new non-artemisinin combination in a Phase 2b study. The...

NewsDesk  @infectiousdiseasenews Last Wednesday, New Mexico state health officials announced during a COVID-19 update the deaths of two people linked to taking the anti-parasitic drug, ivermectin for...

By NewsDesk  @infectiousdiseasenews A treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a WHO Guideline Development Group...